13G Filing: Ariel Investments and Kindred Biosciences Inc. (KIN)
...... (read more)
Kindred Biosciences Inc. (KIN)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Park West Asset Management Peter S. Park | 6,743,893 | $61,841 | +13% | 2.71% |
| 2. | Ariel Investments John W. Rogers | 2,618,040 | $24,007 | +32% | 0.29% |
| 3. | 44,000 | $403 | 0.09% | ||
| 4. | Rubric Capital Management David Rosen | 115,992 | $1,064 | 0.09% | |
| 5. | Alyeska Investment Group Anand Parekh | 410,212 | $3,762 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.50 | 741,840 | Large Shareholder | 6,743,893 | 2019-01-18 | Filing | |
| $9.50 | 845,262 | Large Shareholder | 6,002,053 | 2018-06-20 | Filing | |
| $7.50 | 600,000 | Large Shareholder | 5,156,791 | 2017-07-12 | Filing | |
| $6.65 | 15,311 | Large Shareholder | 4,556,791 | 2017-06-08 | Filing | |
| $6.83 | 155,076 | Large Shareholder | 4,541,480 | 2017-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.57 | 40,000 | Large Shareholder, Officer, Director | 1,906,071 | 2019-01-02 | Filing | |
| $13.28 | 40,000 | Large Shareholder, Officer, Director | 1,946,071 | 2018-12-03 | Filing | |
| $14.68 | 40,000 | Large Shareholder, Officer, Director | 1,986,071 | 2018-11-01 | Filing | |
| $13.28 | 40,000 | Large Shareholder, Officer, Director | 2,026,071 | 2018-10-01 | Filing | |
| $13.30 | 2,885 | Director | 24,928 | 2018-09-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 181,962 | $1,668 | 1.73% | |
| 2. | 500,000 | $4,585 | 0.78% | |
| 3. | 449,574 | $4,123 | 0.4% | |
| 4. | 710,790 | $6,518 | 0.34% | |
| 5. | 70,000 | $642 | 0.09% |
News See All
Should You Buy Kindred Biosciences Inc (KIN)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to...... (read more)
Kindred Biosciences, Inc. (KIN): Hedge Funds and Value Investors Are Crazy About It
Kindred Biosciences Inc (NASDAQ:KIN) is a tiny stock, yet managed to attract high profile hedge funds and value investors. Famed value investor Seth Klarman was the fund's biggest investor at the end...... (read more)
Is Kindred Biosciences Inc (KIN) Going to Burn These Hedge Funds?
Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping...... (read more)
Billionaire Seth Klarman’s Top 3 Micro-Cap Stock Picks ~ Bellatrix Exploration Ltd (BXE), Kindred Biosciences Inc (KIN) and Alliance One International, Inc. (AOI)
The world’s 11th largest hedge fund, Seth Klarman’s Baupost Group, recently filed its 13F with the Securities and Exchange Commission for the end of the first quarter. Klarman founded Baupost Group...... (read more)
Seth Klarman’s Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)
In two filings with the Securities and Exchange Commission, Baupost Group, a hedge fund managed by Seth Klarman, disclosed reducing its position in Enzon Pharmaceuticals Inc (NASDAQ:ENZN) and adding...... (read more)
Billionaire Hedge Funds
